Movement disorder clinic marketing: Parkinson’s cure and progression claims, surgery, stem cell offers and caregiver stories

A Parkinson’s or movement disorder clinic page is read by a person whose hand started shaking last year, by a spouse who has watched a partner’s steps get shorter, by an adult child looking for a second opinion, and by a primary care office that wants a specialist for a patient with a tremor that is not getting better. The clinic may be a neurology practice with a movement disorder specialist, a hospital program that offers surgery, or a therapy service built around exercise and speech. Readers arrive hoping for a cure, and the agencies say there is none. What can the page promise? How should it describe surgery, new tests and the stem cell offers readers will also find? This guide covers what the agencies say and how to turn it into pages, ads and referral materials that stay within the rules.

Five related topics have their own guides and are not repeated here. Emergency lines across a neurology site, device wording in the FDA’s own terms and what the front desk may share with families are covered in our guide to neurology practice marketing. Rehab physicians and their claims are covered in our guide to physiatry practice marketing. Stem cell clinics and the FDA rules behind them are covered in our guide to stem cell clinic advertising. Thinking and memory evaluations are covered in our guide to memory clinic marketing. Study recruitment is covered in our guide to clinical trial recruitment ads. For cure and progression claims in another neurology program, see MS center marketing.

What NINDS, MedlinePlus and FDA say

A movement disorder page starts with what the condition is, how it is diagnosed and what treatment can and cannot do. The sources describe it this way:

• The NINDS page Parkinson’s Disease (last reviewed July 23, 2026) says Parkinson’s affects people in different ways, including when symptoms appear and how fast they get worse. It lists tremor, rigidity, slowed movement and balance problems, and symptoms beyond movement such as depression, anxiety, sleep problems, speech changes and trouble with thinking and memory.
• The same NINDS page says there is no cure for Parkinson’s, but medicines or surgery can help people move more easily and improve other symptoms. It says the main medicine can ease movement symptoms but does not replace lost nerve cells or stop the disease from getting worse, and that symptoms may not completely go away even when the dose is right.
• NINDS says there is no specific, single test that can definitively diagnose Parkinson’s. Doctors use a medical history and a neurological exam, and newer skin and spinal fluid tests can help diagnose it but cannot tell it apart from similar disorders.
• The MedlinePlus page Parkinson’s Disease (last updated September 29, 2025) says there is no specific test, so it can be difficult to diagnose, and that there is no cure. It says surgery and deep brain stimulation can help severe cases.
• The MedlinePlus page Movement Disorders (last updated February 9, 2024) says treatment varies by disorder: medicines can cure some disorders, others get better when an underlying disease is treated, and where there is no cure, the goal of treatment is to improve symptoms and relieve pain.
• The FDA page Important Patient and Consumer Information About Regenerative Medicine Therapies (content current as of April 8, 2024) says regenerative medicine therapies have not been approved to treat any neurological disorder, and names Parkinson’s disease among them.

Two points shape the marketing. First, the agencies describe treatment that eases symptoms, not treatment that ends or reverses the disease, so the page sells care, skill and access, never a cure. Second, NINDS stresses that each person is different, so a page or a story cannot promise one person’s response to another.

Cure, reverse and slow progression claims

Under 15 U.S.C. 45, deceptive acts or practices in commerce are unlawful, and 15 U.S.C. 52 prohibits false advertisements likely to induce the purchase of drugs, devices, services or cosmetics. The FTC staff Health Products Compliance Guidance says claims about the health benefits or safety of health-related products require competent and reliable scientific evidence, and that an advertiser is responsible for the claims its ads convey, including implied ones.

For Parkinson’s, the hardest claim to resist is progression. NINDS says the main medicine does not stop the disease from getting worse, and it describes NIH-supported clinical trials that are testing whether vigorous exercise can help keep Parkinson’s from getting worse. A trial that is still testing a question is not an answer. “Slows Parkinson’s” in an ad for a medicine plan, an exercise class, a diet or a supplement claims something the agency has not said.

Phrases that need rewriting:

• “Reverse your Parkinson’s” or “beat Parkinson’s”. NINDS says there is no cure. Describe what the clinic does: assessment, treatment planning, adjusting medicines and therapy.
• “Our program slows disease progression”. Say what NINDS says exercise can do: improve flexibility, balance, strength and the ability to move, and that people should check with a doctor before starting a new exercise program.
• “Get your old life back” and any other promise of a result. NINDS says symptoms may not completely go away and that people react differently to the same medicine.
• “Natural Parkinson’s protocol” or a supplement that “protects your brain”. NINDS says NIH is funding research to determine whether caffeine, supplements and other foods or nutrients may help prevent or treat Parkinson’s; that is a research question. Our guide to selling supplements in a medical practice covers the wider rules.

Diagnosis and testing pages

Readers want an answer, and a clinic that offers newer tests may want to lead with them. Keep the test pages in the agency’s terms. NINDS says the skin and spinal fluid tests for abnormal protein can help diagnose Parkinson’s but cannot tell it apart from similar disorders, that a dopamine transporter scan can help diagnose it but cannot tell it apart from atypical parkinsonism, and that brain imaging can rule out other disorders. NINDS also says a genetic counselor can help explain what genetic test results mean.

Phrases that need rewriting:

• “One simple test tells you if you have Parkinson’s”. NINDS says there is no specific, single test that can definitively diagnose it; describe the test as one part of an evaluation by a clinician.
• “Know your risk with our genetic panel” with no counseling. Say who explains the results, such as a genetic counselor, and what the result can and cannot tell a person.
• “Early detection lets us stop Parkinson’s before it starts”. No source cited here supports it.

Surgery and device pages

Deep brain stimulation, lesion surgery and focused ultrasound draw readers who have tried medicines for years. NINDS says deep brain stimulation is considered after medicines stop working well or cause difficult side effects, that it helps change the brain activity that causes movement problems but does not cure the disease, and that it does not improve other symptoms, naming speech problems, freezing, balance, anxiety, depression and dementia. NINDS says lesion surgeries permanently destroy small amounts of brain tissue and have been largely replaced by deep brain stimulation, and it describes focused ultrasound as a treatment using sound waves from outside the head.

A surgery page lists who the procedure is considered for, what it can help, what it does not help and who decides, in the words NINDS uses. Name no device brand or manufacturer in ads, and describe any device only within the indication the FDA cleared or approved, in the FDA’s own words, as our neurology guide linked above explains. Surgeon training and board status follow our guide to physician bio pages and board certification.

Phrases that need rewriting:

• “Deep brain stimulation stops your tremor for good”. NINDS says it helps movement symptoms and does not cure the disease.
• “Incisionless cure for tremor”. Describe the procedure, its indication in the FDA’s words and its risks, without a cure claim.
• “Fix your balance and speech with surgery”. NINDS says deep brain stimulation does not improve speech problems, freezing or balance.

Stem cell and regenerative offers

Families searching for Parkinson’s treatment will meet clinics that sell stem cell, cord blood or exosome treatments. The FDA page cited above says these unapproved products require FDA licensure or approval to be marketed, that before approval they require FDA oversight in a clinical trial, and that FDA has received reports of blindness, tumor formation and infections. It says that if a person is being charged for these products or offered them outside a clinical trial, they are likely being deceived and offered a product illegally, and that a listing on clinicaltrials.gov or an FDA registration does not mean a product is legally marketed.

A legitimate movement disorder clinic should not offer these products, refer patients to clinics that do, or place ads next to them. A clinic that runs or refers to an FDA-overseen study describes it as research, with no promise of benefit, as our clinical trial recruitment guide linked above explains. Our stem cell guide linked above covers the FTC cases and the FDA rules in full.

Tremor, dystonia and other movement disorders

A clinic that treats more than Parkinson’s should keep each condition’s page in its own agency’s words. The NINDS page Tremor (last reviewed July 23, 2026) says tremor is not life threatening but may cause challenges and even lead to disabilities, and that although the majority of tremor forms have no cure, treatments are available to help manage symptoms. The NINDS page Dystonia (last reviewed September 12, 2026) says few treatments can stop dystonia or keep it from getting worse, but injections, medicines, surgery and physical therapy can help manage specific symptoms.

Injection clinics for dystonia name no product brand in ads and promise no length of relief; the label and the treating clinician set expectations. Pages for children’s movement disorders, tics and rare genetic conditions follow the same pattern: the agency’s description, the clinic’s services and who to call.

Center, fellowship and program names

Movement disorder programs carry titles from outside bodies: fellowship training, center designations from patient foundations, and research center funding from NINDS, which supports Parkinson’s research centers across the country. The rule is the same for each. Use the exact name as the [naming body] states it, with the years it covers, and check the listing before each campaign. A research center grant does not make a clinic a treatment center, and a clinician’s fellowship does not make the whole practice a designated center.

Phrases that need rewriting:

• “A Parkinson’s Center of Excellence” when no body has named the clinic one. Use the title only as the [naming body] lists it, for the years it covers.
• “NIH-backed Parkinson’s care” because a physician once took part in a funded study. Describe the study role accurately or leave it out.
• “Fellowship-trained team” when one clinician completed the fellowship. Name the clinician and the program, as our physician bio guide linked above explains.

Exercise, therapy and support programs

NINDS lists physical, occupational and speech therapy, voice exercises, massage therapy and acupuncture as complementary therapies some people with Parkinson’s use to help ease symptoms, and it names walking, dancing, yoga, cycling and swimming as physical activity that can help. Exercise classes, voice programs and support groups are good things to advertise. Describe what happens in a session, who leads it and what NINDS says the activity can help with, and leave out progression and cure claims. Therapy marketing is covered in our guides to physical therapy marketing and speech and occupational therapy marketing, and care at home in our guide to home health agency marketing.

Readers with tremor, slowed movement or vision changes need a site that works for them. Large tap targets, forms that forgive shaky input, plain words and a page that works with a keyboard and a screen reader matter here; our guide to website accessibility covers the standards. NINDS notes that symptoms such as depression and anxiety can be part of Parkinson’s. A support page that touches mood gives 988, the Suicide and Crisis Lifeline, for a crisis and 911 for an emergency.

Referrals and partners

Movement disorder clinics grow through primary care offices, general neurologists, therapy practices and home care agencies. Under 42 U.S.C. 1320a-7b(b), the federal anti-kickback statute, it is a crime to knowingly and willfully offer, pay, solicit or receive any remuneration to induce or reward referrals of items or services payable by a federal health care program. Rules on referral fees are also set state by state. Our guide to patient and physician referrals covers the general rules.

For a movement disorder clinic, keep these points:

• Do not give gifts, meals, free services or payments to referring offices, therapy practices or home care agencies in return for patients without counsel’s review.
• Free exercise classes or screenings offered to the public go to counsel first when they lead to services billed to federal programs.
• Referral materials say how to reach the team, how records and imaging come in and how notes go back, without promising a surgery slot or a result.
• Practices that see Medicaid patients follow the rules in our guide to marketing to Medicaid patients.

Privacy, pixels and ads

A visit to a Parkinson’s page, a surgery consult request or a tremor intake form says something about a person’s health. Keep bookings, intake answers and page clicks out of tracking pixels and ad platform tools unless a written agreement covers them; our guide to tracking pixels on practice websites covers the setup. The Google Ads personalized advertising policy lists health among its sensitive interest categories and restricts targeting based on it. Ads can target by place and by search terms, and should not be built from a patient list or a support group roster.

Under 45 CFR 164.501, a reminder about the clinic’s own treatment for an individual, such as a programming visit after surgery, can fall outside the definition of marketing, while a message that promotes a third party’s product generally needs a signed authorization under 45 CFR 164.508. Keep message text neutral, and ask the patient how they and their family want to be contacted.

Patient and caregiver stories

A patient who describes going back to gardening after a medicine change, or a spouse who describes the first support group, can help a reader more than any ad. It is still one person’s experience. Under 16 CFR 255.2, an ad that shows one person’s result on a key attribute is likely to be read as what others will generally achieve, unless the advertiser has substantiation for that or clearly and conspicuously discloses what people can generally expect. “My tremor is gone” is a results claim. Pair it with the NINDS wording that Parkinson’s affects people in different ways and that symptoms may not completely go away.

Get a signed authorization under 45 CFR 164.508 where the clinic is a covered entity, from the patient, and from the caregiver for anything the caregiver shares about the patient. NINDS says some people with Parkinson’s develop problems with thinking and memory, so make sure the patient can take part in the decision, and when someone else signs as their personal representative, follow counsel’s direction. Video of tremor or walking shows the patient’s body and condition; get consent for the footage itself and let the person review the final cut. Our guide to testimonials and before and after photos covers the full rules.

Illustration: two movement disorder clinic pages

Illustration: a page reads “Reverse Parkinson’s naturally. Our Center of Excellence uses cutting-edge stem cell therapy and a breakthrough protocol that slows progression. One test tells you for sure. Our deep brain stimulation patients throw away their canes. Book now.” It promises a cure, claims a title no body gave it, offers a product FDA says is not approved for any neurological disorder, overstates a test and turns one story into a promise.

Illustration: a second page for the same clinic reads “NINDS says Parkinson’s affects people in different ways and that there is no cure, but medicines or surgery can help people move more easily. Our team, led by [Clinician name, license], completed [fellowship name, as stated by the training program] in [year]. We assess movement, thinking, mood and sleep, adjust treatment over time and work with therapists on walking and speech. For people whose medicines no longer work well, we discuss whether deep brain stimulation fits; NINDS says it helps movement symptoms and does not cure the disease. Our weekly exercise class focuses on balance and strength; check with your doctor first. Call [phone].” It uses the agency’s wording, states training exactly and describes care without a promise.

Checklist before a movement disorder campaign goes live

• No cure, reverse, beat or slows progression claims for any medicine, surgery, class, diet or supplement.
• Agency wording for what treatment can and cannot do, with NINDS or MedlinePlus named and dated.
• Test pages say no single test definitively diagnoses Parkinson’s, and genetic testing names who explains results.
• Surgery pages say who the procedure is considered for, what it does not help and that it does not cure; device wording stays within the FDA’s indication.
• No stem cell, cord blood or exosome offers, referrals or ad placements; studies are described as research with no promise of benefit.
• Tremor, dystonia and other conditions each use their own NINDS or MedlinePlus wording.
• Center, fellowship and research titles match the naming body’s current listing, with years.
• No drug, device or product brand names in ads, and no doses on the page.
• No gifts, meals or payments to referral sources without counsel’s review.
• Bookings and intake answers stay out of pixels and ad audiences; message text is neutral.
• Stories have signed authorizations from the patient and any caregiver who shares details, and a disclosure of what people can generally expect.
• Support pages give 988 for a crisis and 911 for an emergency.

How we help

We build websites, local search, Google Ads and AI front desk tools for independent practices and health businesses, including neurology, movement disorder and therapy programs. For a movement disorder clinic, that means a site that describes care in NINDS and MedlinePlus wording, states training and titles exactly as the naming body lists them, explains surgery without promises and works for readers with tremor and slowed movement, plus booking forms that keep diagnoses and symptoms off the web and away from tracking tools. We do not decide how care is delivered; your clinicians do. Our tools are built with HIPAA in mind. We confirm in writing what a BAA covers before any patient information flows through a tool, and if it is not covered, we do not route patient information through it. We are not a healthcare provider and we do not give legal or medical advice. We do not sell lead lists and we do not pay for referrals. For the wider rules, see our healthcare marketing rules hub.

Sources

• NINDS: Parkinson’s Disease (last reviewed July 23, 2026)
• NINDS: Tremor (last reviewed July 23, 2026)
• NINDS: Dystonia (last reviewed September 12, 2026)
• MedlinePlus: Parkinson’s Disease (last updated September 29, 2025)
• MedlinePlus: Movement Disorders (last updated February 9, 2024)
• FDA: Important Patient and Consumer Information About Regenerative Medicine Therapies (content current as of April 8, 2024)
• 15 U.S.C. 45: Unfair methods of competition unlawful
• 15 U.S.C. 52: Dissemination of false advertisements
• FTC: Health Products Compliance Guidance (December 2022)
• 42 U.S.C. 1320a-7b: Criminal penalties for acts involving Federal health care programs
• 45 CFR 164.501: Definitions
• 45 CFR 164.508: Uses and disclosures for which an authorization is required
• 16 CFR 255.2: Consumer endorsements
• Google Ads: Personalized advertising policy

More in Physician specialty marketing